While all groups have demonstrated an inspiring level of dedication and passion, I have always been moved by patients’ ...

Europe follows a similar pattern, with data from the EU Clinical Trials Information System (CTIS) estimating that less than 0 ...

When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...

Nucala's approval offers hope for uncontrolled COPD. This new drug reduces flare-ups, a key benefit for Black Americans.

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

The new review of Alzheimer’s disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs.

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

Chinese Pharmaceutical Companies Dominating Global Research & Development Landscape Of Bispecific ADC Market Says Kuick ...

There’s been a leap in potential new medicines being tested in clinical trials for Alzheimer’s, according to a new annual ...